|
2011
|
Invention
|
Crystal form h imatinib mesylate for pharmaceutical use. The invention relates to particular crys... |
|
2009
|
Invention
|
Use of pyrimidine compounds in the preparation of parasiticides.
The invention relates to the us... |
|
2007
|
Invention
|
Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/o... |
|
|
Invention
|
2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related com... |
|
|
Invention
|
Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases.
treatme... |
|
|
Invention
|
Use of pkc inhibitors in particular indolylmaleimide derivatives in ocular diseases. The present ... |
|
|
Invention
|
Biomarkers for alzheimer's disease progression. This invention relates generally to the analytica... |
|
|
Invention
|
Nanoparticle compositions. A method of Nanoparticle-based therapy for a mammalian subject is disc... |
|
|
Invention
|
Method for making solid dispersions of highly crystalline therapeutic compounds. A process for pr... |
|
|
Invention
|
Imidazo-pyridine derivatives for modulating protein kinase activity. The present application desc... |
|
|
Invention
|
Smac peptidomimetics useful as iap inhibitors. The present invention is directed to a compound of... |
|
|
Invention
|
Inhibitors of undecaprenyl pyrophosphate synthase. The present invention relates to compounds tha... |
|
|
Invention
|
Use of trifluoromethyl substituted benzamides in the treatment of neurological disorders. The inv... |
|
|
Invention
|
Use of hdac inhibitors for the treatment of lymphomas. The present invention relates to the use o... |
|
|
Invention
|
Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same... |
|
|
Invention
|
Organic compounds. The invention relates to pharmaceutical compositions containing inhibitors of ... |
|
|
Invention
|
Phenylacetic acid derivatives as cox-2 inhibitors. Compounds of formula (I) pharmaceutically acce... |
|
|
Invention
|
Use of organic compounds. A method to prevent, delay the progression or reduce, the Gastrointesti... |
|
|
Invention
|
Biomarkers for the progression of alzheimer's disease. The genetic polymorphism LRRK2 (leuci... |
|
|
Invention
|
Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treati... |
|
|
Invention
|
Polymorphs of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propena... |
|
|
Invention
|
Process for making salts of n-hydroxy-3-⏧4-⏧⏧⏧2-(2-methyl-1h-indol-3-yl)ethyl]amino]met... |
|
|
Invention
|
Process for making n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino] methyl]phenyl]-2e-2-p... |
|
|
Invention
|
Method for making silicone hydrogel contact lenses with good coating durability. The invention pr... |
|
|
Invention
|
Salts of n-hydroxy-3-⏧4-⏧⏧⏧2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl&rsq... |
|
|
Invention
|
Stabilized insulin-like growth factor polypeptides. The invention relates to stabilized polypepti... |
|
|
Invention
|
Use of tgf-β antagonists in treatment of parathyroid-related disorders. The present inventio... |
|
|
Invention
|
Organic compounds. The present invention provides heterocyclic derivatives that modulate the acti... |
|
|
Invention
|
Aminothiazole derivatives and their uses as antibacterial agents. The present application describ... |
|
|
Invention
|
Aldosterone synthase and/or 11β-hydroxylase inhibitors. The present invention provides a com... |
|
|
Invention
|
Methods of use and nutritional compositions of touchi extract. Disclosed is a method and composit... |
|
|
Invention
|
Method of treatment of hereditary hemochromatosis. The present invention relates to the use of Co... |
|
|
Invention
|
Salts and crystal modifications thereof. The invention relates to salts of 1-(2-Fluoro-phenyl)-3-... |
|
|
Invention
|
Heated roller compaction process for making pharmaceutical compositions. A process for using a he... |
|
|
Invention
|
Use of organic compounds. Use of a ERRy agonist or pharmaceutically acceptable salt thereof, for ... |
|
|
Invention
|
Function of estrogen related receptor gamma (err&ggr;) in increasing mitochondrial biogenesis. Th... |
|
|
Invention
|
Biomarkers for chronic transplant dysfunction. The invention relates to the analysis and identifi... |
|
|
Invention
|
Hcv/hiv inhibitors an their uses. The present application describes organic compounds of formula ... |
|
|
Invention
|
Combinations of therapeutic agents for treating cancer. A combination of an mTOR inhibitor compou... |
|
|
Invention
|
Compositions and methods of use for antibodies of c-met. Antibodies and fragments that bind to th... |
|
|
Invention
|
New compounds. The present invention provides organic compounds of the following structure; A-L1-... |
|
|
Invention
|
Mutations and polymorphisms of insr |
|
|
Invention
|
Methods of treating multiple myeloma using il-17 binding molecules. An IL-17 binding molecule, in... |
|
2006
|
Invention
|
Pdf inhibitors.
The invention relates to novel compounds that are inhibitors of peptidyl deformy... |
|
|
Invention
|
Crystalline form f of imatinib mesylate. The invention relates to the F-crystal form, G-crystal f... |
|
|
Invention
|
Methods of treating arthritis using il-1β binding molecules. This invention relates to methods em... |
|
|
Invention
|
Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridi... |
|
|
Invention
|
Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrim... |
|
|
Invention
|
Use of antibody-ligand binding to characterise diseases.
We have found that when an antibody bin... |
